| Xylylene Diisocyanate Composition, Polymerizable Composition For Optical Materials, Resin, Molded Body, Optical Element And Lens | MITSUI CHEMICALS, INC. | Aug 17, 2026 | WUESTHOFF & WUESTHOFF |
| Methods Of Treating Chronic Kidney Disease With Dapagliflozin | ASTRAZENECA AB | Jun 16, 2026 | WUESTHOFF & WUESTHOFF |
| Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs Thereof | MADRIGAL PHARMACEUTICALS, INC. | Jun 9, 2026 | WUESTHOFF & WUESTHOFF |
| Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione | AMGEN (EUROPE) GMBH | May 19, 2026 | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI |
| High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use Thereof | EISAI R&D MANAGEMENT CO., LTD. | Apr 1, 2026 | WUESTHOFF & WUESTHOFF |
| Pharmaceutical Composition, Methods For Treating And Uses Thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Sep 16, 2025 | WUESTHOFF & WUESTHOFF |
| Solid Oral Formulation Of Fenretinide | LAURENT PHARMACEUTICALS | Sep 9, 2025 | WUESTHOFF & WUESTHOFF |
| New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) | NOVARTIS AG | Jul 23, 2025 | WUESTHOFF & WUESTHOFF |
| Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension | ACTELION PHARMACEUTICALS LTD | Feb 21, 2025 | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI |
| Xylylene Diisocyanate Composition, Modified Xylylene Diisocyanate Composition, Polymerizable Composition, Resin, Molded Body, Optical Element, And Lens | MITSUI CHEMICALS, INC. | Feb 12, 2025 | WUESTHOFF & WUESTHOFF |